PROTAC IRAK4 degrader-1 |
| رقم الكتالوجGC62197 |
PROTAC IRAK4 degrader-1 عبارة عن مادة تحلل كيناز 4 (IRAK4) مرتبطة بمستقبلات بروتاك إنترلوكين -1 المستندة إلى Cereblon والمستخلص من براءة اختراع US20190192668A1 المركب I-210 ، مما يجعل 20-50٪ ، و> 50٪ تدهور IRAK4 عند 0.01 ، 0.1 ، و 1 ميكرومتر في خلايا OCI-LY-10 ، على التوالي
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2360533-90-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
PROTAC IRAK4 degrader-1 is a PROTAC interleukin-1 receptor-associated kinase 4 (IRAK4) degrader extracted from patent US20190192668A1 Compound I-210, makes 20-50%, and >50% IRAK4 degradation at 0.01, 0.1, and 1 μM in OCI-LY-10 cells, respectively[1].
[1]. Nello Mainolfi, et al. Irak degraders and uses thereof. US20190192668A1.
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *